Social context and health consequences of the antipsychotics introduction

Annals of Clinical Psychiatry

Volumn 17, Issue 3, 2005, Pages 141-146

  Kirkby, Kenneth C ^a  

^a UNIVERSITY OF TASMANIA   (Australia)

Author keywords

Antipsychotics; Deinstitutionalization; Health; Health outcomes; History; Social

Indexed keywords

CHLORPROMAZINE; NEUROLEPTIC AGENT;

CLINICAL PRACTICE; DEINSTITUTIONALIZATION; DEMENTIA; EXPERIENCE; HISTORY; HUMAN; MARKETING; OUTCOMES RESEARCH; PRIORITY JOURNAL; PSYCHOSIS; REVIEW; RISK BENEFIT ANALYSIS; SOCIAL ENVIRONMENT; SOCIOLOGY; TREATMENT OUTCOME;

ANTIPSYCHOTIC AGENTS; DEINSTITUTIONALIZATION; DYSKINESIA, DRUG-INDUCED; HISTORY, 20TH CENTURY; HUMANS; MENTAL DISORDERS; NEUROLEPTIC MALIGNANT SYNDROME; PSYCHOTIC DISORDERS; SOCIAL CHANGE; UNITED STATES;

EID: 23844455893     PISSN: 10401237     EISSN: 15473325     Source Type: Journal    
DOI: 10.1080/10401230591002066     Document Type: Review

References (37)

1. Moncrieff J: An investigation into the precedents of modern drug treatment in psychiatry. History of Psychiatry 1999; 10:475-490
2. Delay J, Deniker P, Harl JM: Utilisation en thérapeutique psychiatrique d'une phénothiazine d'action centrale élective (4560 RP). Ann Méd Psychol 1952; 110:112-117
3. Sen G, Bose KC: Rauwolfia serpentina: A new Indian drug for insanity and high blood pressure. Indian Medical World 1931; 11:194-201
4. Kline NS: Use of Rauwolfia Serpentina Benth. In neuropsychiatric conditions. Ann NY Acad Sci 1954; 59:107-132
5. Deniker P: From chlorpromazine to tardive dyskinesia (brief history of the neuroleptics). Psychiatr J Univ Ott 1989; 14:253-259
6. Andermann AAJ: Physicians, fads, and pharmaceuticals: A history of aspirin. McGill Journal of Medicine 1996; 2:115-120
7. Schwartz RS: Paul Ehrlich's magic bullets. New England Journal Medicine 2004; 350:1079-1080
8. Laborit H, Huguenard P, Alluaume R: Un nouveau stabilisateur végétatif (le 4560 RP). Presse Méd 1952; 60:206-208
9. Linford Rees W (in conversation with D Healy): The place of clinical trials in the development of psychopharmacology. History of Psychiatry 1997; 8:001-020
10. Carlsson A: A half-century of neurotransmitter research: Impact on neurology and psychiatry. Bioscience Reports 2001; 21:691-710
11. Pletscher A: The discovery of antidepressants: A winding path. Experientia 1991; 47:4-8
12. Hirschfeld RM: History and evolution of the monoamine hypothesis of depression. J Clin Psychiatry 2000; 61:4-6
13. Griesinger W: Die Pathologie und Therapie der Psychischen Krankheiten. Stuttgart: Krabbe, 1845
14. Kirkby KC: After the gold rush: The expansion of asylums in country Victoria in the 1860s. Occas Pap Med Hist Aust 1999; 9
15. Shepherd M: Neurolepsis and the psychopharmacological revolution: Myth and reality. History of Psychiatry 1994; 5:089-096
16. Q1 16. Bennett D: The drive towards the community. In: Berrios GE, Freeman H, eds. 150 years of British Psychiatry, 1841-1991. city? Gaskell Press, 1991:321-332
17. Ødegaard Ø: Pattern of discharge from Norwegian psychiatric hospitals before and after the introduction of the psychotropic drugs. American Journal of Psychiatry 1964; 120:772-778
18. Dax EC: Asylum to community: The development of the mental hygiene service in Victoria, Australia. Melbourne: F. W. Cheshire, for the World Federation for Mental Health, 1961
19. Herman DB, Susser ES, Jandorf L, Lavelle J, Bromet EJ: Homelessness among individuals with psychotic disorders hospitalized for the first time: Findings from the Suffolk County Mental Health Project. Am J Psychiatry 1998; 155:109-113
20. Fazel S, Danesh J: Serious mental disorder in 23000 prisoners: A systematic review of 62 surveys. Lancet 2002; 359:545-50
21. Murray CJ, Lopez AD (Eds): Global Burden of Disease. A comprehensive assessment of mortality and disability from diseases, injuries, and risk factors in 1990 and projected to 2020. World Health Organisation: Harvard University Press, 1996
22. Lacro JP, Dunn LB, Dolder CR, Leckband SG, Jeste DV: Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: A comprehensive review of recent literature. J Clin Psychiatry. 2002; 63:892-909
23. Andrews G, Sanderson K, Corry J, Issakidis C, Lapsley H: Cost-effectiveness of current and optimal treatment for schizophrenia. Br J Psychiatry 2003; 183:427-435
24. McIntyre R, Katzman M: The role of atypical antipsychotics in bipolar depression and anxiety disorders. Bipolar Disord 2003; 5 Suppl 2:20-35
25. Carson WH, Kitagawa H: Drug development for anxiety disorders: new roles for atypical antipsychotics. Psychopharmacol Bull 2004; 38:38-45
26. McGorry PD, Yung AR, Phillips LJ, Yuen HP, Francey S, Cosgrave EM, Germano D, Bravin J, McDonald T, Blair A, Adlard S, Jackson H: Randomized controlled trial of interventions designed to reduce the risk of progression to first-episode psychosis in a clinical sample with subthreshold symptoms. Arch Gen Psychiatry 2002; 59:921-928
27. Killian JG, Kerr K, Lawrence C, Celermajer DS: Myocarditis and cardiomyopathy associated with clozapine. Lancet 1999; 354:1841-1845
28. Tarsy D: History and definition of tardive dyskinesia. Clinical Neuropharmacology 1983; 6:91-99
29. Lyon ER: A review of the effects of nicotine on schizophrenia and antipsychotic medications. Psychiatr Serv 1999; 50:1346-1350
30. Hartwell CE: The schizophrenogenic mother concept in American psychiatry. Psychiatry 1996; 59:274-297
31. Laing RD: The Divided Self: An Existential Study in Sanity and Madness. City: Penguin, 1976
32. Szasz T: The origin of psychiatry: The alienist as nanny for troublesome adults. History of Psychiatry 1995; 6:001-019
33. Scull A: Psychiatry and social control in the nineteenth and twentieth centuries. Hist Psychiatry 1991; 2:149-169
34. The tightening grip of big pharma (editorial): Lancet 2001; 35:1141
35. Nye RA: The evolution of the concept of medicalization in the late twentieth century. Journal of History of the Behavioral Sciences 2003; 39:115-129
36. Eisenberg L: Mindlessness and brainlessness in psychiatry. Br J Psychiatry 1986; 148:497-508
37. Tourney G: A history of therapeutic fashions in psychiatry, 1800-1966. Am J Psychiatry 1967; 124:784-96